Join Ibex at ECP 2023 in Dublin to learn how they transform cancer diagnosis by harnessing artificial intelligence to support routine practice at pathology labs worldwide.
There will be three clinical presentations from studies conducted at leading medical centers in the United States, the UK and Europe, showing the clinical utility and benefits of using AI during primary diagnosis of gastric and breast biopsies:
- Multi-site Multi Reader Study on Artificial Intelligence-Assisted Primary Diagnosis of Gastric Biopsies
by Manuel Rodriguez-Justo, MD – University College London, UK
Sunday, September 10, 8:40, Ecocem Room - Multi-reader Study of a Fully Automated Artificial Intelligence Solution for HER2 IHC Scoring in Breast Cancer Biopsies
by Savitri Krishnamurthy, MD – MD Anderson Cancer Center, United States
Tuesday, September 12, 9:40, Liffey Hall 1 - A Multi-Feature AI Solution for Diagnosis Support of Breast Excisions: A Clinical Validation Study
by Glenn Broeckx, MD – Antwerp University Hospital (UZA), Belgium
Tuesday, September 12, 11:20, Liffey Hall 1
A full list of their scientific program can be viewed here. Visit them on the exhibition floor (booth #23) for a live demo with their team of pathologists. You can review cases firsthand, using insights and tools from the most widely deployed AI platform in pathology.
If you are not able to make to the event in person, please encourage your colleagues to visit. Feel free to reach out via email/phone and for the essentials from the clinical presentations after the event as well.
Source: Ibex
